首页> 外文期刊>BMC Musculoskeletal Disorders >Complete twelve month bone remodeling with a bi-phasic injectable bone substitute in benign bone tumors: a prospective pilot study
【24h】

Complete twelve month bone remodeling with a bi-phasic injectable bone substitute in benign bone tumors: a prospective pilot study

机译:用双阶段可注射骨替代良性骨肿瘤完成12个月骨重塑:一项潜在的试点研究

获取原文
           

摘要

Benign primary bone tumors are commonly treated by surgery involving bone grafts or synthetic bone void fillers. Although synthetic bone grafts may provide early mechanical support while minimizing the risk of donor-site morbidity and disease transmission, difficult handling properties and less than optimal transformation to bone have limited their use. In a prospective series, patients with benign bone tumors were treated by minimal invasive intervention with a bi-phasic and injectable ceramic bone substitute (CERAMENT? BONE VOID FILLER, BoneSupport, Sweden) with the hypothesis that open surgery with bone grafting might be avoided. The defects were treated by either mini-invasive surgery (solid tumors) or percutaneous injection (cysts) and followed clinically and radiologically for 12?months. CT scan was performed after 12?months to confirm bone remodeling of the bone substitute. All patients were allowed full weight bearing immediately after surgery. Fourteen patients with a median age of 13?years (range 7–75) were consecutively recruited during 11?months. Eleven lesions were bone cysts (eight unicameral and three post-traumatic) and three were solid benign tumors. The median size of the lesions was 40?mL (range 1–152). The most common location was humerus (n?=?10). After 12?months the defects completely or partially filled with median 18?mL (range 5–28) of bone substitute demonstrated full resolution (Neer Classification grade I) in 11 patients, partial resolution (Neer II) in 2 patients and in 1 patient the cyst persisted (Neer III). No lesions required recurrent surgery during the observation period. No post-operative fracture or infection was recorded. Minimal invasive treatment with a bi-phasic and injectable ceramic bone substitute might offer an alternative to regular bone grafting due to convenient handling properties and rapid bone remodeling. ClinicalTrials NCT02567084 Release Date 10/01/2015
机译:良性原发性骨肿瘤通常通过涉及骨移植或合成骨空隙填料的手术治疗。虽然合成骨移植物可以提供早期机械载体,同时最小化供体现场的发病率和疾病传播的风险,难以处理性能,并且对骨骼的最佳变换有限。在一个潜在的系列中,通过用双阶段和可注射陶瓷骨代替代(纹纹陶瓷骨替代品(纹纹,瑞典)的假设来治疗良性骨肿瘤的患者,可能避免了开放手术的假设。通过微创手术(实体肿瘤)或经皮注射(囊肿)治疗缺陷,并在临床上和放射学前进行12?个月。 CT扫描在12个月后进行以确认骨替代品的骨质重塑。手术后立即允许所有患者全重轴承。在11个月内招募了十四名中位数13岁的患者13岁(范围7-75)。十一个病变是骨囊(八个单色和三种后妊娠),三种是固体良性肿瘤。病变的中值为40?ml(范围1-152)。最常见的位置是肱骨(n?=?10)。 12岁以下?几个月后,骨代替骨替代的中位数18?ml(范围5-28)的缺陷在11名患者中表现出全分辨率(Neer分类等级I),2例患者部分分辨率(Neer II)和1例患者囊肿持续存在(Neer III)。在观察期内没有病变需要复发手术。没有记录术后骨折或感染。用双阶段和可注射陶瓷骨代替的最小侵入性治疗可能是由于方便的处理性能和快速骨重塑而替代常规骨移植。 ClinicalTrials NCT02567084发布日期10/01/2015

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号